<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0221027" disease_type="Disease or Syndrome" abbrv="">Good's syndrome</z:e>, also known as <z:hpo ids='HP_0100522'>thymoma</z:hpo> with <z:hpo ids='HP_0005387'>combined immunodeficiency</z:hpo>, is rare </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> may precede, arise concurrently with or follow the diagnosis of <z:hpo ids='HP_0100522'>thymoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to <z:hpo ids='HP_0003473'>myasthenia</z:hpo> gravis and <z:e sem="disease" ids="C0221027" disease_type="Disease or Syndrome" abbrv="">Good's syndrome</z:e>, <z:e sem="disease" ids="C0030472" disease_type="Neoplastic Process" abbrv="">paraneoplastic syndromes</z:e> associated with <z:hpo ids='HP_0100522'>thymoma</z:hpo> can also be manifested with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, such as pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:mp ids='MP_0000334'>agranulocytosis</z:mp>, <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, pernicious <z:hpo ids='HP_0001903'>anemia</z:hpo>, and <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> is a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in one or more lineages, ineffective hematopoiesis, and potential precursors of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>One proposed pathogenesis of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> is autoantibodies that directly reject against hematopoietic cells, but this situation is rare in <z:hpo ids='HP_0100522'>thymoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Herein, we report a <z:hpo ids='HP_0100522'>thymoma</z:hpo> patient with unique <z:e sem="disease" ids="C0030472" disease_type="Neoplastic Process" abbrv="">paraneoplastic syndromes</z:e> who developed <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> prior to <z:e sem="disease" ids="C0221027" disease_type="Disease or Syndrome" abbrv="">Good's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Early and accurate diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> is important for disease management, especially in patients whose <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> is possibly derived from <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>For <z:hpo ids='HP_0100522'>thymoma</z:hpo> patients with <z:hpo ids='HP_0002719'>recurrent infections</z:hpo>, comprehensive immunologic studies to exclude the possibility of <z:e sem="disease" ids="C0221027" disease_type="Disease or Syndrome" abbrv="">Good's syndrome</z:e> and prophylactic intravenous immunoglobulin infusion in suitable candidates are warranted </plain></SENT>
</text></document>